Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
- PMID: 22157632
- DOI: 10.1136/bjophthalmol-2011-301236
Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
Comment in
-
Resistance, not tachyphylaxis or tolerance.Br J Ophthalmol. 2012 Aug;96(8):1153-4. doi: 10.1136/bjophthalmol-2012-301823. Epub 2012 Apr 17. Br J Ophthalmol. 2012. PMID: 22510583 No abstract available.
Comment on
-
Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab.Br J Ophthalmol. 2012 Jan;96(1):21-3. doi: 10.1136/bjo.2011.203893. Epub 2011 Jul 6. Br J Ophthalmol. 2012. PMID: 21733918
-
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation.Br J Ophthalmol. 2012 Jan;96(1):14-20. doi: 10.1136/bjo.2011.204685. Epub 2011 Jul 26. Br J Ophthalmol. 2012. PMID: 21791509
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical